4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0000947871-23-000438
10% owner sold 102,630 shares at an average $2.16 ($221,994)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC 10% owner | 2023-04-05 | Sale | −4,687 | $2.18 | $10,218 | 187,100 | I: show line 1 in the form |
| ORBIMED ADVISORS LLC 10% owner | 2023-04-05 | Sale | −25,220 | $2.18 | $54,980 | 1,006,591 | I: show line 2 in the form |
| ORBIMED ADVISORS LLC 10% owner | 2023-04-05 | Sale | −63,058 | $2.18 | $137,466 | 2,516,599 | I: show line 3 in the form |
| ORBIMED ADVISORS LLC 10% owner | 2023-04-06 | Sale | −487 | $2.00 | $974 | 186,613 | I: show line 4 in the form |
| ORBIMED ADVISORS LLC 10% owner | 2023-04-06 | Sale | −2,620 | $2.00 | $5,240 | 1,003,971 | I: show line 5 in the form |
| ORBIMED ADVISORS LLC 10% owner | 2023-04-06 | Sale | −6,558 | $2.00 | $13,116 | 2,510,041 | I: show line 6 in the form |
| Open-market sales · 102,630 sh · avg $2.16 · $221,994 | |||||||
Loading xslF345X04/ownership.xml…